Trial Profile
Broad Effectiveness: Study With Aripiprazole
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2009
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb